Clinical-stage biopharmaceutical company developing immunotherapies for allergic and autoimmune diseases and other serious unmet medical needs
Clinical-stage biopharmaceutical company developing immunotherapies for allergic and autoimmune diseases and other serious unmet medical needs. It uses its PCFiT and Apitope technology platforms to build a pipeline through internal development and external partnerships, and is developing a molecular allergy diagnostics platform.